Prophylaxis and therapy for chikungunya virus infection

218Citations
Citations of this article
203Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Chikungunya virus (CHIKV) is a recently reemerged arbovirus responsible for a massive outbreak of infection in the Indian Ocean region and India that has a very significant potential to spread globally because of the worldwide distribution of its mosquito vectors. CHIKV induces a usually self-limited disease in humans that is characterized by fever, arthralgia, myalgia, and rash; however, cases of severe CHIKV infection have recently been described, particularly in adults with underlying condition and neonates born to viremic mothers. Methods. Human polyvalent immunoglobulins were purified from plasma samples obtained from donors in the convalescent phase of CHIKV infection, and the preventive and curative effects of these immunoglobulins were investigated in 2 mouse models of CHIKV infection that we developed. Results. CHIKV immunoglobulins contain anti-CHIKV antibodies and exhibit a high in vitro neutralizing activity and a powerful prophylactic and therapeutic efficacy against CHIKV infection in vivo, including in the neonate. Conclusions. Administration of CHIKV immunoglobulins may constitute a safe and efficacious prevention strategy and treatment for individuals exposed to CHIKV who are at risk of severe infection, such as neonates born to viremic mothers and adults with underlying conditions. These results provide a proof-of-concept for purifying human immunoglobulins from plasma samples from patients in the convalescent phase of an emerging infectious disease for which neither prevention nor treatment is available. © 2009 by the Infectious Diseases Society of America. All rights reserved.

References Powered by Scopus

Functional role of type I and type II interferons in antiviral defense

2124Citations
N/AReaders
Get full text

Infection with chikungunya virus in Italy: an outbreak in a temperate region

1236Citations
N/AReaders
Get full text

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak

952Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Chikungunya virus and the global spread of a mosquito-borne disease

645Citations
N/AReaders
Get full text

Biology and pathogenesis of chikungunya virus

592Citations
N/AReaders
Get full text

Chikungunya: A re-emerging virus

487Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Couderc, T., Khandoudi, N., Grandadam, M., Visse, C., Gangneux, N., Bagot, S., … Lecuit, M. (2009). Prophylaxis and therapy for chikungunya virus infection. Journal of Infectious Diseases, 200(4), 516–523. https://doi.org/10.1086/600381

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 74

58%

Researcher 35

27%

Professor / Associate Prof. 16

13%

Lecturer / Post doc 3

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 56

43%

Medicine and Dentistry 28

21%

Immunology and Microbiology 24

18%

Biochemistry, Genetics and Molecular Bi... 23

18%

Article Metrics

Tooltip
Mentions
News Mentions: 1
References: 2

Save time finding and organizing research with Mendeley

Sign up for free